Physician profile
John Abboud
NPI 1417957416
$1,230.58
in general payments reported to CMS, 2019-2025
19 companies · $27.73 in 2025
The $27.73 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.81 · 2020: $41.00 · 2021: $481 · 2022: $365 · 2023: $265 · 2025: $27.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $223.35 | 2019-2022 | |
| Medtronic, INC. | $182.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $180.33 | 2020-2023 | |
| Amgen INC. | $128.98 | 2021-2023 | Repatha |
| Bard Peripheral Vascular, INC. | $91.80 | 2023 | Rotarexs 6 F X 135 Cm |
| Merck Sharp & Dohme LLC | $87.20 | 2022-2023 | Verquvo |
| Pfizer INC. | $56.05 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.35 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $40.75 | 2021-2022 | |
| Esperion Therapeutics, INC. | $32.32 | 2021-2023 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $30.16 | 2021-2023 | Camzyos |
| Bridgebio Pharma, INC. | $27.73 | 2025 | Attruby |
| Abbott Laboratories | $17.99 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $16.17 | 2021 | |
| Beckman Coulter, INC. | $14.59 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.34 | 2021 | |
| Novo Nordisk INC | $13.41 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $12.97 | 2023 | Inpefa |
| G Medical Diagnostic Services, INC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Abboud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.